| Douglas ULLRICH (2024). Janela de saÃda de um acelerador linear para feixe de elétrons, para uso na produção de radioisótopos, sistemas e métodos. Patent Number: BR112019015503. |
|
Patent |
Materials |
| William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. (2024). APPARATUS FOR PRODUCING MOLYBDENUM-99 (99MO) FROM A PLURALITY OF MOLYBDENUM-100 (100MO) TARGETS BY A PHOTO-NUCLEAR REACTION ON THE 100MO TARGETS. Patent Number: BR112015029336B1. |
|
Patent |
Materials |
| Томас ШПРЕТЕР ФОН КРЕДЕНШТАЙН; Сержит Бхимарао ДИКСИТ; Эрик ЭСКОБАР-КАБРЕРА; Пола Ирэн ЛАРИО; Дэвид Кай Юэнь ПУН et al. (2023). DEVELOPMENT OF STABLE HETERODIMERIC ANTIBODY WITH MUTATIONS IN Fc DOMAIN. Patent Number: RU2810540C2. |
|
Patent |
Health |
| Folgueira Judit Anido; Johan Fransson; Jean Philippe Julien; Swetha Raman; Suarez Joan Seoane et al. (2025). Antibodies against lif and uses thereof. Patent Number: NZ755004B2. |
|
Patent |
Agriculture |
| (2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2. |
|
Patent |
|
| (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A. |
|
Patent |
|
| (2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T. |
|
Patent |
|
| (2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A. |
|
Patent |
|
| (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A. |
|
Patent |
|
| (2021). ANTIBODY. Patent Number: PT3311170T. |
|
Patent |
|
| (2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2. |
|
Patent |
|
| (2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0. |
|
Patent |
|
| (2025). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES BINDING BCMA AND CD3 AND THEIR USES. Patent Number: FR23C1012I2. |
|
Patent |
|
| (2023). Antibodies to tigit. Patent Number: IL298111A. |
|
Patent |
|
| (2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2. |
|
Patent |
|